ArticleJournal of Korean Neurosurgical Society2020
Radiosurgery for Cerebral Arteriovenous Malformation (AVM) : Current Treatment Strategy and Radiosurgical Technique for Large Cerebral AVM.
Article in Journal of Korean Neurosurgical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Diagnostic Performance of TOF, 4D MRA, Arterial Spin-Labeling, and Susceptibility-Weighted Angiography Sequences in the Post-Radiosurgery Monitoring of Brain AVMs.AJNR. American journal of neuroradiology · 2025Pooled it
- Accelerated Volume-Staged Stereotactic Radiosurgery for Large Cerebral Arteriovenous Malformations: A Single Institutional Experience.Advances in radiation oncology · 2026Article
- Evaluation of Hemorrhage Risk and Predictors Following Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Retrospective Single-center Study.Advances in radiation oncology · 2026Article
- Prognostic value of nidus sphericity in brain AVMs treated with Gamma Knife Radiosurgery: a preliminary study.Diagnostic and interventional radiology (Ankara, Turkey) · 2026Article
- Susceptibility-Based MRI in Cerebral Arteriovenous Malformations: From Venous Drainage to Physiological Biomarkers-A Narrative Review.Biomedicines · 2026Review
- Neuraxial Anesthesia in Parturients With Intracranial Arteriovenous Malformations: A Case Report.Cureus · 2025Article
- Complications after Gamma Knife Radiosurgery for Brain AVMs: Predictive factors for symptomatic radionecrosis.Acta neurochirurgica · 2025Article
- Successful Endoscopic Resection of a Chronic Expanding Hematoma Following Gamma Knife Surgery for Cerebral Arteriovenous Malformation: A Case Report.NMC case report journal · 2025Article
- Clarifying misconceptions in modern neurosurgery: an open letter to the neurosurgical community.Neurosurgical review · 2024Article
- Brain arteriovenous malformation flow after stereotactic radiosurgery: Role of quantitative MRA.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024Article
- Article
- Efficacy of Dose-Escalated Hypofractionated Radiosurgery for Arteriovenous Malformations.Cureus · 2024Article
- Delayed cyst formation after radiosurgery for arteriovenous malformation: A case report and critical review.Surgical neurology international · 2024Article
- Time-Dosed Stereotactic Radiosurgery for the Treatment of Cerebral Arteriovenous Malformations: An Early Institution Experience and Case Series.Neurosurgery practice · 2023Article
- Review
- Factors Affecting Volume Reduction Velocity for Arteriovenous Malformations After Treatment With Dose-Stage Stereotactic Radiosurgery.Frontiers in oncology · 2021Article
- Radiotherapy and radiosurgery for intracranial lesions in Africa: Insights from 3 country case studies: A systematic review.Neuro-oncology advancesReview
- Impact of Grid Size on Dose Calculations for Cranial Tumors.Journal of medical physicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arteriovenous malformations (AVMs) are congenital anomalies of the cerebrovascular system. AVM harbors 2.2% annual hemorrhage risk in unruptured cases and 4.5% annual hemorrhage risk of previously ruptured cases. Stereotactic radiosurgery (SRS) have been shown excellent treatment outcomes for patients with small- to moderated sized AVM which can be achieved in 80-90% complete obliteration rate with a 2-3 years latency period. The most important factors are associated with obliteration after SRS is the radiation dose to the AVM. In our institutional clinical practice, now 22 Gy (50% isodose line) dose of radiation has been used for treatment of cerebral AVM in single-session radiosurgery. However, dose-volume relationship can be unfavorable for large AVMs when treated in a single-session radiosurgery, resulting high complication rates for effective dose. Thus, various strategies should be considered to treat large AVM. The role of pre-SRS embolization is permanent volume reduction of the nidus and treat high-risk lesion such as AVM-related aneurysm and high-flow arteriovenous shunt. Various staging technique of radiosurgery including volume-staged radiosurgery, hypofractionated radiotherapy and dose-staged radiosurgery are possible option for large AVM. The incidence of post-radiosurgery complication is varied, the incidence rate of radiological post-radiosurgical complication has been reported 30-40% and symptomatic complication rate was reported from 8.1% to 11.8%. In the future, novel therapy which incorporate endovascular treatment using liquid embolic material and new radiosurgical technique such as gene or cytokine-targeted radio-sensitization should be needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.